Biopharma Daily Stock Updates - 01/05/21

Updated: Jan 13

$XBI -0.35% 📉


COVID:

$CERC (+10.61%) - Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing Antibody, in Patients Hospitalized with COVID-19 ARDS

https://ir.cerecor.com/press-releases/detail/114


$MRNA (-2.28%) - Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel

https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use


PIPELINE:

$RGNX (-0.13%) - RGX-314 update & RGX-202 announcement

http://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-update-rgx-314-and-pivotal-program-treatment


$PGEN (-12.60%) - Precigen Announces Clearance of IND to Initiate Phase I Study of PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)

https://investors.precigen.com/news-releases/news-release-details/precigen-announces-clearance-ind-initiate-phase-i-study-prgn


$MYOV (-3.10%) - Myovant Sciences Announces U.S. Availability of ORGOVYX™ for the Treatment of Advanced Prostate Cancer

https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-announces-us-availability-orgovyxtm-treatment


FINANCIALS:

$RYTM (+3.82%) - Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M

https://ir.rhythmtx.com/news-releases/news-release-details/rhythm-pharmaceuticals-announces-sale-priority-review-voucher


0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE